Red blood cell membrane disorders

被引:213
作者
Tse, WT
Lux, SE
机构
[1] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1111/j.1365-2141.1999.01130.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent discovery of the specific molecular defects in many patients with hereditary spherocytosis and hereditary elliptocytosis/pyropoikilocytosis partially clarifies the molecular pathology of these diseases. HE and HPP are caused by defects in the horizontal interactions that hold the membrane skeleton together, particularly the critical spectrin self-association reaction. Single gene defects cause red cells to elongate as they circulate, by a unknown mechanism, and are clinically harmless. The combination of two defective genes or one severe α spectrin defect and a thalassaemia-like defect in the opposite allele (α(LELY)) results in fragile cells that fragment into bizarre shapes in the circulation, with haemolysis and sometimes life-threatening anaemia. A few of the α spectrin defects are common, suggesting they provide an advantage against malaria or some other threat. HS, in contrast, is nearly always caused by family-specific private mutations. These involve the five proteins that link the membrane skeleton to the overlying lipid bilayer: α and β spectrin, ankyrin, band 3 and protein 4.2. Somehow, perhaps through loss of the anchorage band 3 provides its lipid neighbours (Peters et al, 1996), microvesiculation of the membrane surface ensues, leading to spherocytosis, splenic sequestration and haemolysis. Future research will need to focus on how each type of defect causes its associated disease, how the spleen aggrevates membrane skeleton defects (a process termed 'conditioning'), how defective red cells are recognized and removed in the spleen, and why patients with similar or even identical defects can have different clinical severity. Emphasis also needs to be given to improving diagnostic tests, particularly for HS, and exploring new options for therapy, like partial splenectomy, which can ameliorate symptoms while better protecting patients from bacterial sepsis and red cell parasites, and perhaps from atherosclerosis (Robinette and Fraumeni, 1977) and venous thrombosis (Stewart et al, 1996).
引用
收藏
页码:2 / 13
页数:12
相关论文
共 120 条
[1]   DEFICIENT RED-CELL SPECTRIN IN SEVERE, RECESSIVELY INHERITED SPHEROCYTOSIS [J].
AGRE, P ;
ORRINGER, EP ;
BENNETT, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (19) :1155-1161
[2]   INHERITANCE PATTERN AND CLINICAL-RESPONSE TO SPLENECTOMY AS A REFLECTION OF ERYTHROCYTE SPECTRIN DEFICIENCY IN HEREDITARY SPHEROCYTOSIS [J].
AGRE, P ;
ASIMOS, A ;
CASELLA, JF ;
MCMILLAN, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) :1579-1583
[3]   PARTIAL DEFICIENCY OF ERYTHROCYTE SPECTRIN IN HEREDITARY SPHEROCYTOSIS [J].
AGRE, P ;
CASELLA, JF ;
ZINKHAM, WH ;
MCMILLAN, C ;
BENNETT, V .
NATURE, 1985, 314 (6009) :380-383
[4]  
Alloisio N, 1997, BLOOD, V90, P414
[5]  
Alloisio N, 1996, BLOOD, V88, P1062
[6]   SP-ALPHA-V/41 - A COMMON SPECTRIN POLYMORPHISM AT THE ALPHA-IV-ALPHA-V DOMAIN JUNCTION - RELEVANCE TO THE EXPRESSION LEVEL OF HEREDITARY ELLIPTOCYTOSIS DUE TO ALPHA-SPECTRIN VARIANTS LOCATED IN TRANS [J].
ALLOISIO, N ;
MORLE, L ;
MARECHAL, J ;
ROUX, AF ;
DUCLUZEAU, MT ;
GUETARNI, D ;
POTHIER, B ;
BAKLOUTI, F ;
GHANEM, A ;
KASTALLY, R ;
DELAUNAY, J .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2169-2177
[7]  
ALLOISIO N, 1993, BLOOD, V81, P2791
[8]  
BAKLOUTI F, 1992, BLOOD, V79, P2464
[9]   beta-Spectrin Campinas: A novel shortened beta-chain variant associated with skipping of exon 30 and hereditary elliptocytosis [J].
Basseres, DS ;
Pranke, PHL ;
Sales, TSI ;
Costa, FF ;
Saad, STO .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) :579-585
[10]   β-spectrin Promissao:: A translation initiation codon mutation of the β-spectrin gene (ATG→GTG) associated with hereditary spherocytosis and spectrin deficiency in a Brazilian family [J].
Bassères, DS ;
Vicentim, DL ;
Costa, FF ;
Saad, STO ;
Hassoun, H .
BLOOD, 1998, 91 (01) :368-369